Mutations in the fusion protein cleavage site of avian paramyxovirus serotype 4 confer increased replication and syncytium formation in vitro but not increased replication and pathogenicity in chickens and ducks.
To evaluate the role of the F protein cleavage site in the replication and pathogenicity of avian paramyxoviruses (APMVs), we constructed a reverse genetics system for recovery of infectious recombinant APMV-4 from cloned cDNA. The recovered recombinant APMV-4 resembled the biological virus in growth characteristics in vitro and in pathogenicity in vivo. The F cleavage site sequence of APMV-4 (DIQPR↓F) contains a single basic amino acid, at the -1 position. Six mutant APMV-4 viruses were recovered in which the F protein cleavage site was mutated to contain increased numbers of basic amino acids or to mimic the naturally occurring cleavage sites of several paramyxoviruses, including neurovirulent and avirulent strains of NDV. The presence of a glutamine residue at the -3 position was found to be important for mutant virus recovery. In addition, cleavage sites containing the furin protease motif conferred increased replication and syncytium formation in vitro. However, analysis of viral pathogenicity in 9-day-old embryonated chicken eggs, 1-day-old and 2-week-old chickens, and 3-week-old ducks showed that none the F protein cleavage site mutations altered the replication, tropism, and pathogenicity of APMV-4, and no significant differences were observed among the parental and mutant APMV-4 viruses in vivo. Although parental and mutant viruses replicated somewhat better in ducks than in chickens, they all were highly restricted and avirulent in both species. These results suggested that the cleavage site sequence of the F protein is not a limiting determinant of APMV-4 pathogenicity in chickens and ducks.
Virginia-Maryland Regional College of Veterinary Medicine, University of Maryland, College Park, MD, USA.
Shin-Hee
SH
Kim
Sa
S
Xiao
Heather
H
Shive
Peter L
PL
Collins
Siba K
SK
Samal
D000595:Amino Acid Sequence; D000818:Animals; D000914:Antibodies, Viral / Q000276:immunology; D018109:Avulavirus / Q000145:classification / Q000235:genetics / Q000276:immunology / Q000472:pathogenicity*; D045463:Avulavirus Infections / Q000662:veterinary / Q000821:virology; D001483:Base Sequence; D001921:Brain / Q000473:pathology / Q000821:virology; D002460:Cell Line; D002645:Chickens / Q000821:virology*; D003588:Cytopathogenic Effect, Viral; D004372:Ducks / Q000821:virology*; D015726:Giant Cells / Q000821:virology*; D006801:Humans; D007150:Immunohistochemistry; D007700:Kinetics; D008969:Molecular Sequence Data; D050505:Mutant Proteins / Q000378:metabolism; D009154:Mutation / Q000235:genetics*; D009474:Neurons / Q000473:pathology / Q000821:virology; D059748:Proteolysis; D059386:Reverse Genetics; D012703:Serotyping; D014760:Viral Fusion Proteins / Q000737:chemistry / Q000235:genetics*; D014771:Virion / Q000378:metabolism; D014779:Virus Replication / Q000235:genetics*
D000914:Antibodies, Viral; D050505:Mutant Proteins; D014760:Viral Fusion Proteins